ACAD
ACADIA Pharmaceuticals Inc.
Sign up for free!
Get instant access to stock market data and news with our free APIs.
Real-time data
- Listing exchange
- NASDAQ Stock Exchange
- Price
- $14.39
- Day High
- $14.5
- Day Low
- $14
- Day Open
- $14.06
- Volume
- 93622
- Day Change
- 1.95%
Latest news data for ACAD
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Acadia Pharmaceuticals Inc. of Class Action Lawsuit and Upcoming Deadline – ACAD
globenewswire.com
FDA AdComm Rejects Nuplazid But Acadia's Race Isn't Run Yet (NASDAQ:ACAD)
seekingalpha.com
With 7.2% CAGR, Neurodegenerative Diseases Drugs Market Size to Surpass Around USD 62,786.2 Million by 2028
globenewswire.com
DNB Asset Management AS Trims Position in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)
etfdailynews.com
Q2 2022 EPS Estimates for ACADIA Pharmaceuticals Inc. Cut by Jefferies Financial Group (NASDAQ:ACAD)
etfdailynews.com
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Stake Boosted by Nordea Investment Management AB
etfdailynews.com
Cantor Fitzgerald Comments on ACADIA Pharmaceuticals Inc.’s FY2023 Earnings (NASDAQ:ACAD)
etfdailynews.com
Analysts Set Expectations for ACADIA Pharmaceuticals Inc.’s FY2023 Earnings (NASDAQ:ACAD)
etfdailynews.com
3 Big Ideas From Citigroup With Up to 80% Upside – 24
247wallst.com
ACADIA Pharmaceuticals (NASDAQ:ACAD) Price Target Cut to $20.00
etfdailynews.com